Inside the
Courts
An Update From Skadden Securities Litigators
CONTENTS
U.S. SUPREME COURT 2
Class Certificaton ......................................2
Amgen Inc. v. Conn. Ret. Pla ns and Trust Funds, No. 11-1085
(U.S. Feb. 27, 2013)
Statutes of Limitations ................................. 2
Gabelli v. Sec. & Exch . Comm’n, No. 11-1274 (U.S. Feb. 27, 2013)
CLASS CERTIFICATION 3
In re Computer Sci s. Corp. Sec. Litig., No. 1:11-cv-610
(E.D. Va. Dec. 19, 2012)
DIRECTORS AND DIRECTORS’ DUTIES 3
Derivative Litigation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Ark. Teacher Ret. Sys. v. Moz ilo, No. 10-56340 (9th Cir. Jan. 10, 2013)
Mergers and Acquisitions ...............................4
In re Celera Corp. S’ holder Litig., No. 212, 2012
(Del. Dec. 27, 2012, revised Jan. 2, 2013)
In re Novell, Inc. S’h older Litig., No. 6032-VCN
(Del. Ch. Jan. 3, 2013)
DISCOVERY 5
In re Merck & Co., Inc. Sec., Der ivative & “ERISA” Litig.,
MDL No. 05-1658 (SRC) (D.N.J. Dec. 12, 2012)
EXCHANGE ACT 6
Kleinman v. Elan Cor p., No. 11-3706-cv (2d Cir. Feb. 1, 2013)
EXPERT WITNESSES 6
Fed. Hous. Fin. Agenc y v. JP Morgan Chase & Co., No. 11 Civ. 6188 (DLC)
(S.D.N.Y. Dec. 3, 2012)
FRAUD-ON-THE-MARKET THEORY 6
State v. Marsh & McLenna n Cos., Inc., No. SC S059386
(Or. Dec. 13, 2012)
FOREIGN CORPORATIONS 7
In re Satyam Com puter Servs. Ltd. Sec . Litig., No. 09 MD 2027 (BSJ)
(S.D.N.Y. Jan. 2, 2013)
FORWARD-LOOKING STATEMENTS 7
In re WebMD Health Corp. Sec. Lit ig., No. 11 Civ. 5382 (JFK)
(S.D.N.Y. Jan. 2, 2013)
INSIDER TRADING CLAIMS 8
Gibbons v. Malone, No. 11-3620-cv (2d. Cir. Jan. 7, 2013)
INVESTMENT C OMPANY ACT 8
Kasilag v. Hartford Inv. Fin . Servs., LLC, No. 11-1083 (RMB/K MW)
(D.N.J. Dec. 17, 2012)
LOSS CAUSATION 8
Solow v. Citigroup, Inc ., No. 12-2499-cv (2d Cir. Jan. 15, 2013)
MATERIALITY 9
Filing v. Phipps, No. 11-4157 (6th Cir. Oct. 23, 2012)
SCIENTER 9
In re VeriFone Holdings, Inc. Sec . Litig., No. 11-15860
(9th Cir. Dec. 21, 2012)
Iowa Pub. Emp.’s Ret. Sys. v. Deloitte & Touche LLP,
No. 12 Civ. 2136 (JPO) (S.D.N.Y. Jan. 23, 2013)
Sarafin v. BioMimetic Therapeutics, Inc., No. 3:11-0653
(M.D. Tenn. Jan. 10, 2013)
SECONDARY ACTOR LIAB ILITY 11
In re DVI Inc. Sec. Litig., No. 03-5336 (E.D. Pa. Jan. 4, 2013)
Meridian Hori zon Fund, L.P. v. Tremont Grp. Holdings, Inc.,
No. 09 Civ. 3708 (S.D.N.Y. Dec. 11, 2012)
SECURITIES ACT C LAIMS 11
N.J. Carpente rs Health Fund v. Royal Bank of Scotlan d Grp., PLC,
No. 12-1707-cv (2d Cir. Mar. 1, 2013)
Silverstrand In vs. v. AMAG Pharm., Inc., No. 11-2063 (1st Cir. Feb. 4, 2013)
SLUSA PRECLUSION 12
Freeman Invest ments, L.P. v. Pacific Life Ins. Co., No. 09-55513
(9th Cir. Jan. 2, 2013)
STAN DI NG 13
In re Century Alu minum Co. Sec. Litig., No. 11-15599 (9th Cir. Jan. 2, 2013)
In re Am. Int. Grp., Inc. S ec. Litig., No. 04 Civ. 8141 (DAB)
(S.D.N.Y. Jan. 7, 2013)
March 2013 | Volume 5 | Issue 1
